Bestzyme’s Mellia™ Brazzein receives FDA “no questions” letter

Bestzyme is pleased to announce a flagship product Mellia™ Brazzein, has officially received the “No Questions” letter from the U.S. Food and Drug Administration (FDA) regarding its GRAS (Generally Recognized as Safe) status. The GRAS designation recognizes it as general-purpose sweetener for a wide range of applications in the food and beverage industry.

This milestone follows the successful Self-GRAS certification completed in early July 2024. It marks the official FDA approval of Mellia™ Brazzein, affirming the product’s safety and regulatory compliance. With this GRAS approval, Bestzyme has received international recognition for its innovative breakthrough in the natural sweetener industry.

Brazzein is a naturally occurring sweet protein found in the fruit of the West African plant Oubli (Pentadiplandra brazzeana Baillon). Now, Bestzyme has enabled its sustainable and industrial-scale production through precision fermentation.

Mellia™ Brazzein features pure sweet taste, high sweetness and flavor modifying function. As a next-generation, high-quality sweetener, it is ideal for sugar-reduction solutions across a wide range of applications, including beverages, dairy products, confectionery, chocolate, health supplement, and catering.

 

Innovations in Food (& Beverage) Technology is a quarterly magazine distributed globally both in Print and Digital formats. www.innovationsfood.com.  Twitter: @Innovfoodtech.  Instagram: @innovationsinfoodtechnology.  Linkedin: www.linkedin.com/in/terry-prior52